Based on preclinical (animal and cellular) data only, inhibition of NNMT by 5-Amino-1MQ is theorised to: Raise intracellular NAD+ levels Activate SIRT1 and other sirtuins (proteins linked to metabolic regulation) Reduce fat cell (adipocyte) size and proliferation Improve insulin sensitivity These effects have been demonstrated in mouse models (Neelakantan et al., 2019), but robust human clinical trial data are currently absent
No, Retatrutide is not yet approved by Health Canada
Some patients with severe glutathione synthetase deficiency also develop recurrent bacterial infections, probably due to defective granulocyte function
M.DobbsR
BPC-157: Benefits, Side Effects, Dosage, and More Disclaimer : BPC-157 (body protective compound-157) has not been authorized by the FDA and is intended for research purposes only
According to research published in PMC (NIH), plasma GHK-Cu levels are approximately 200 ng/mL at age 20 but decline to just 80 ng/mL by age 60